Patents by Inventor Jose Carlos Garcia-Garcia

Jose Carlos Garcia-Garcia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11649336
    Abstract: Poly(acrylic acid)-based superabsorbent polymer (SAP) in a feed stream is converted into poly(acrylic acid) (PAA) in an extensional flow device. The total energy used to degrade the SAP into PAA is less than about 50 MJ/kg SAP.
    Type: Grant
    Filed: June 8, 2021
    Date of Patent: May 16, 2023
    Assignee: The Procter & Gamble Company
    Inventors: Dimitris Ioannis Collias, John Andrew McDaniel, Gary Wayne Gilbertson, Martin Ian James, Arsen Arsenov Simonyan, Jose Carlos Garcia-Garcia
  • Publication number: 20220266322
    Abstract: Superabsorbent fiber (SAF) in a feed stream is converted into soluble polymers in an extensional flow device. The total energy used to degrade the SAF into soluble polymers is less than about 50 MJ/kg SAF.
    Type: Application
    Filed: February 3, 2022
    Publication date: August 25, 2022
    Inventors: Juliane KAMPHUS, Bruno Johannes EHRNSPERGER, Arsen Arsenov SIMONYAN, Dimitris Ioannis COLLIAS, John Andrew McDANIEL, Martin Ian JAMES, Gary Wayne GILBERTSON, Jose Carlos GARCIA-GARCIA, Jacqueline Besinaiz THOMAS, Yiping SUN
  • Patent number: 11331280
    Abstract: A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising (2-hydroxyethyl) dimethylsulfonium with a counterion wherein the counterion is selected from chloride, bromide or iodide.
    Type: Grant
    Filed: November 6, 2019
    Date of Patent: May 17, 2022
    Assignees: The Procter & Gamble Company, The Cleveland Clinic Foundation
    Inventors: Stanley Leon Hazen, Jose Carlos Garcia-Garcia, Jodie Michelle Reed, Lori Ann Reinsalu, Vincent Peter Sica, Timothy R Baker
  • Patent number: 11246844
    Abstract: A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I):
    Type: Grant
    Filed: May 31, 2017
    Date of Patent: February 15, 2022
    Assignees: The Procter & Gamble Company, The Cleveland Clinic Foundation
    Inventors: Stanley Leon Hazen, Jose Carlos Garcia-Garcia, George Franklin Gerberick, John August Wos, Xiaodong Gu, Michael Reilly, Mark Robert Sivik, Jodie Michelle Reed, David Blair Cody
  • Publication number: 20210388172
    Abstract: Poly(acrylic acid)-based superabsorbent polymer (SAP) in a feed stream is converted into poly(acrylic acid) (PAA) in an extensional flow device. The total energy used to degrade the SAP into PAA is less than about 50 MJ/kg SAP.
    Type: Application
    Filed: June 8, 2021
    Publication date: December 16, 2021
    Inventors: Dimitris Ioannis Collias, John Andrew McDaniel, Gary Wayne Gilbertson, Martin Ian James, Arsen Arsenov Simonyan, Jose Carlos Garcia-Garcia
  • Patent number: 10849866
    Abstract: A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising a compound set forth in Formula (I):
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: December 1, 2020
    Assignees: The Procter & Gamble Company, The Cleveland Clinic Foundation
    Inventors: Jose Carlos Garcia-Garcia, George Franklin Gerberick, Stanley Leon Hazen, Xiaodong Gu
  • Patent number: 10786479
    Abstract: The invention provides a method of inhibiting the conversion of carnitine to trimethylamine (TMA) and lowering TMAO in an individual comprising administering to the individual one or more compositions comprising a compound set forth in Formula (I): Wherein the compound is administered in an amount effective to inhibit conversion of carnitine to TMA in the individual.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: September 29, 2020
    Assignees: The Procter & Gamble Company, The Cleveland Clinic Foundation
    Inventors: Stanley Leon Hazen, Jose Carlos Garcia-Garcia, George Franklin Gerberick, John August Wos, David Thomas Stanton, Thomas Alfred Inglin, Michael Reilly, Angela Jane Deutsch, Jodie Michele Reed, David Blair Cody
  • Patent number: 10780072
    Abstract: The invention provides one or more methods of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual comprising administering to the individual one or more compositions comprising a compound set forth in Formula (I): wherein the compound is administered in an amount effective to inhibit formation of trimethylamine (TMA) from choline in the individual.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: September 22, 2020
    Assignees: The Procter & Gamble Company, The Cleveland Clinic Foundation
    Inventors: Stanley Leon Hazen, Jose Carlos Garcia-Garcia, George Franklin Gerberick, John August Wos, David Thomas Stanton, Thomas Alfred Inglin, Michael Reilly, Angela Jane Deutsch, Jodie Michele Reed, David Blair Cody
  • Patent number: 10751301
    Abstract: A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising a compound set forth in Formula (I):
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: August 25, 2020
    Assignees: The Procter & Gamble Company, The Cleveland Clinic Foundation
    Inventors: Jose Carlos Garcia-Garcia, George Franklin Gerberick, Michael Reilly, Stanley Leon Hazen, Xiaodong Gu
  • Patent number: 10675256
    Abstract: A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising a compound set forth in Formula (I):
    Type: Grant
    Filed: October 2, 2018
    Date of Patent: June 9, 2020
    Assignees: The Procter & Gamble Company, The Cleveland Clinic Foundation
    Inventors: Jose Carlos Garcia-Garcia, George Franklin Gerberick, John August Wos, Stanley Leon Hazen, Xiaodong Gu
  • Publication number: 20200138740
    Abstract: A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising (2-hydroxyethyl) dimethylsulfonium with a counterion wherein the counterion is selected from chloride, bromide or iodide.
    Type: Application
    Filed: November 6, 2019
    Publication date: May 7, 2020
    Inventors: Stanley Leon HAZEN, Jose Carlos GARCIA-GARCIA, Jodie Michelle REED, Lori Ann REINSALU, Vincent Peter Sica, Timothy R Baker
  • Publication number: 20200138887
    Abstract: A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising an extract of Mikania.
    Type: Application
    Filed: November 6, 2019
    Publication date: May 7, 2020
    Inventors: Stanley Leon HAZEN, Jose Carlos GARCIA-GARCIA, Jodie Michelle REED, Lori Ann REINSALU, Vincent Peter Sica, Timothy R Baker
  • Publication number: 20200115685
    Abstract: A formulation comprising an ingestible carrier and an isolated strain of Bifidobacterium longum.
    Type: Application
    Filed: November 8, 2019
    Publication date: April 16, 2020
    Applicant: Alimentary Health Ltd.
    Inventors: Jose Carlos GARCIA-GARCIA, Michael John Janusz, Barry Kiely, Eileen Frances Murphy, Liam O'Mahony
  • Patent number: 10519430
    Abstract: A formulation comprising an ingestible carrier and an isolated strain of Bifidobacterium longum.
    Type: Grant
    Filed: February 4, 2019
    Date of Patent: December 31, 2019
    Assignee: Alimentary Health Ltd.
    Inventors: Jose Carlos Garcia-Garcia, Michael John Janusz, Barry Kiely, Eileen Frances Murphy, Liam O'Mahony
  • Publication number: 20190153408
    Abstract: A formulation comprising an ingestible carrier and an isolated strain of Bifidobacterium longum.
    Type: Application
    Filed: February 4, 2019
    Publication date: May 23, 2019
    Inventors: Jose Carlos Garcia-Garcia, Michael John Janusz, Barry Kiely, Eileen Frances Murphy, Liam O'Mahony
  • Publication number: 20190099390
    Abstract: A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising a compound set forth in Formula (I):
    Type: Application
    Filed: October 2, 2018
    Publication date: April 4, 2019
    Inventors: Jose Carlos GARCIA-GARCIA, George Franklin GERBERICK, Stanley Leon HAZEN, Xiaodong GU
  • Publication number: 20190099384
    Abstract: A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising a compound set forth in Formula (I):
    Type: Application
    Filed: October 2, 2018
    Publication date: April 4, 2019
    Inventors: Jose Carlos GARCIA-GARCIA, George Franklin GERBERICK, Michael REILLY, Stanley Leon HAZEN, Xiaodong GU
  • Publication number: 20190099389
    Abstract: A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO in an individual by providing a composition comprising a compound set forth in Formula (I):
    Type: Application
    Filed: October 2, 2018
    Publication date: April 4, 2019
    Inventors: Jose Carlos GARCIA-GARCIA, George Franklin GERBERICK, John August Wos, Stanley Leon HAZEN, Xiaodong GU
  • Patent number: 10233433
    Abstract: A formulation comprising an ingestible carrier and an isolated strain of Bifidobacterium longum.
    Type: Grant
    Filed: August 26, 2016
    Date of Patent: March 19, 2019
    Assignees: Alimentary Health Ltd., The Procter & Gamble Company
    Inventors: Jose Carlos Garcia-Garcia, Michael John Janusz, Barry Kiely, Eileen Frances Murphy, Liam O'Mahony
  • Patent number: 10213407
    Abstract: The invention provides a method of inhibiting the conversion of choline or carnitine to trimethylamine (TMA) and lowering TMAO in an individual comprising administering to the individual a composition comprising a compound set forth in FORMULA (I): The invention also provides for a method of inhibiting the production of TMA by bacteria comprising administering to the individual a composition comprising a compound set forth in FORMULA (I) wherein the compound is administered in an amount effective to inhibit formation of trimethylamine (TMA) from choline or carnitine in the individual.
    Type: Grant
    Filed: December 1, 2016
    Date of Patent: February 26, 2019
    Assignees: THE PROCTER & GAMBLE COMPANY, THE CLEVELAND CLINIC FOUNDATION
    Inventors: Jose Carlos Garcia-Garcia, Stanley Leon Hazen, John August Wos